New data backs Transgene’s lung cancer vaccine
September 15, 2008
nospam@example.com (Clear the Smoke) wrote an interesting post today on
Here’s a quick excerpt
French biotech company Transgene said on Monday that further clinical results showed the survival benefits of its therapeutic vaccine TG4010 in treating patients with advanced non-small cell lung cancer.
Read the rest of this great post here
Posted in Non-Small-Cell, Research, Treatment
